Considerations on discontinuing natalizumab for the treatment of multiple sclerosis

Joseph R. Berger, Diego Centonze, Giancarlo Comi, Christian Confavreux, Gary Cutter, Gavin Giovannoni, Ralf Gold, Hans Peter Hartung, Fred Lublin, Augusto Miravalle, Xavier Montalban, Paul O'Connor, Tomas Olsson, Chris H. Polman, Olaf Stuve, Jerry S. Wolinsky, Tjalf Ziemssen